PDS Biotechnology Corp. (PDSB)
0.2899
-0.01
(-3.37%)
USD |
NASDAQ |
Sep 09, 13:25
PDS Biotechnology Total Liabilities (Quarterly) : 12.39M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.39M |
| March 31, 2026 | 20.77M |
| December 31, 2025 | 21.28M |
| September 30, 2025 | 25.25M |
| June 30, 2025 | 24.52M |
| March 31, 2025 | 24.67M |
| December 31, 2024 | 26.35M |
| September 30, 2024 | 30.45M |
| June 30, 2024 | 29.58M |
| March 31, 2024 | 31.82M |
| December 31, 2023 | 33.26M |
| September 30, 2023 | 32.70M |
| June 30, 2023 | 31.31M |
| March 31, 2023 | 27.44M |
| December 31, 2022 | 33.01M |
| September 30, 2022 | 27.83M |
| June 30, 2022 | 4.576M |
| March 31, 2022 | 5.166M |
| December 31, 2021 | 3.988M |
| September 30, 2021 | 3.891M |
| June 30, 2021 | 4.398M |
| March 31, 2021 | 3.387M |
| December 31, 2020 | 3.761M |
| September 30, 2020 | 3.420M |
| June 30, 2020 | 3.079M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.047M |
| December 31, 2019 | 2.794M |
| September 30, 2019 | 3.801M |
| June 30, 2019 | 5.199M |
| March 31, 2019 | 6.598M |
| December 31, 2018 | 2.231M |
| September 30, 2018 | 6.688M |
| June 30, 2018 | 13.87M |
| March 31, 2018 | 32.33M |
| December 31, 2017 | 30.25M |
| September 30, 2017 | 26.59M |
| June 30, 2017 | 28.72M |
| March 31, 2017 | 21.25M |
| December 31, 2016 | 21.64M |
| September 30, 2016 | 19.07M |
| June 30, 2016 | 8.664M |
| March 31, 2016 | 9.043M |
| December 31, 2015 | 11.62M |
| September 30, 2015 | 15.86M |
| June 30, 2015 | 10.55M |
| March 31, 2015 | 11.06M |
| December 31, 2014 | 8.092M |
| September 30, 2014 | 8.23M |
| June 30, 2014 | |
| March 31, 2014 | 4.062M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.807M |
| Shareholders Equity (Quarterly) | -3.580M |
| Debt to Equity Ratio | -1.219 |
| Current Ratio | 0.5692 |
| Net Debt Paydown Yield | 5.92% |